PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.\', \'Laboratory of Structural Biology and Drug Discovery, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.\', \'National Clinical Research Center for Infectious Diseases, Shenzhen Third People\'s Hospital, Southern University of Science and Technology, Shenzhen, 518112, China.\', \'College of Chemistry and Molecular Engineering, Beijing Nuclear Magnetic Resonance Center, Peking University, Beijing, 100871, China.\', \'Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, China.\', \'National Clinical Research Center for Infectious Diseases, Shenzhen Third People\'s Hospital, Southern University of Science and Technology, Shenzhen, 518112, China. szdsyy@aliyun.com.\', \'State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China. huang.hao@pku.edu.cn.\', \'Laboratory of Structural Biology and Drug Discovery, Peking University Shenzhen Graduate School, Shenzhen, 518055, China. huang.hao@pku.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-020-20718-8
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33473130
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all